By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hadasit Bio Holdings 

Tel Aviv      Israel
Phone: n/a Fax: n/a



Company News
Hadasit Bio Holdings Signed A Letter Of Intent For An Investment Of 2 Million Dollars With A Chinese Business Group; The Investment Will Be Executed At A Premium Of 57% 6/29/2015 9:47:39 AM
KAHR Medical, a Hadasit Bio Holdings Portfolio Company, to Raise $2.5M 9/11/2013 9:48:47 AM
Hadasit Bio Holdings Flagship Portfolio Company Enlivex Therapeutics Ltd. Awarded Orphan Drug Status for ApoCell, Inc. Treatment by the FDA 4/4/2013 10:18:21 AM
Hadasit Bio Holdings Interviewed by Wall Street Reporter 7/16/2012 10:32:51 AM
Hadasit Bio Holdings to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13, 2011 8/31/2011 11:46:35 AM
Hadasit Bio Holdings Begins Trading in U.S. through Launch of ADR 6/28/2011 6:11:48 AM
Cell Cure Neurosciences Ltd., a Subsidiary of BioTime (BTIM.PK) and Hadasit Bio Holdings, Enters into an Exclusive License Option Agreement with Teva Pharmaceutical Industries Limited (TEVA) 10/11/2010 12:23:02 PM
Significant Creation of Value by Hadasit Bio Holdings 4/19/2010 12:10:12 PM
Hadasit Bio Holdings Portfolio Company Tolarex Ltd. to Commence Phase I/IIa Trial of a Treatment for GVHD 4/20/2009 9:20:12 AM
KAHR Medical Raises $500K From Hadasit Bio Holdings and the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel 1/28/2009 9:43:43 AM